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Abstract: Chromosomal instability (CIN) is a common feature of tumours that leads to increased 
genetic diversity in the tumour and poor clinical outcomes. There is considerable interest in 
understanding how CIN comes about and how its contribution to drug resistance and metastasis 
might be counteracted. In the last decade a number of CIN model systems have been developed in 
Drosophila that offer unique benefits both in understanding the development of CIN in a live animal 
as well as giving the potential to do genome wide screens for therapeutic candidate genes. This 
review outlines the mechanisms used in several Drosophila CIN model systems and summarizes 
some significant outcomes and opportunities that they have produced. 
Keywords: aneuploidy; cell cycle; checkpoint; chromosomal instability; DNA damage; Drosophila; 
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1. Introduction 
The acquisition of mutations is a driving force in the formation of any tumour, as these 
mutations represent the genetic diversity from which aberrantly proliferative cells can emerge. 
Genomic instability, or an increased mutation rate, can be generated by numerous cellular defects, 
such as lack of DNA repair, and these typically give a strong predisposition to tumorigenesis [1]. 
Chromosomal instability, or CIN, refers to an increased rate of DNA changes on the largest scale: 
gain or loss of whole chromosomes or chromosome sections. As a common form of genomic 
instability, CIN is linked to tumorigenesis, particularly in solid tumours, where the frequency of 
chromosomal aberrations can be as high as 90% [2]. There are several reasons why CIN might be 
found so often in tumours: some common oncogenic mutations tend to promote CIN by disrupting 
mitosis, some tumours typically only progress with the gain or loss of specific chromosome arms, 
and for a tumour to go on to metastasize seems to require the kind of dramatic rearrangements that 
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CIN generates [3]. Inducing CIN in otherwise normal mouse models is able to double the rate of 
spontaneous tumour formation [4], and in human cancers CIN is associated with significantly worse 
clinical outcomes [5]. Because CIN generates genetic diversity in tumours it is thought to promote 
drug resistance and relapses following chemotherapy. For these reasons there has been considerable 
research into the causes and possible therapies for chromosomal instability. 
One of the problems in trying to understand the onset of CIN in tumours is that by the time they 
are detected, they have divided unstably many times and become so genetically diverse that it is hard 
to identify the specific changes that induced the CIN. In theory, by examining many clinical CIN 
tumour samples we should be able to find the common changes, but the limited studies available 
have not clearly identified causal mutations [6]. An alternative approach, testing specific mitotic 
defects in culture or animal models, has shown that CIN can be caused by a range of defects in the 
attachment of chromosomes to the spindle as well as by loss of checkpoints, elevated DNA damage 
or replication stress [7]. This wide range of possible mechanisms may explain why it has been 
difficult to identify individual causal mutations in specific tumours, and also raises clinical 
challenges. It may be obvious that CIN is a dangerous cellular phenotype that we would like to 
prevent, but CIN prevention is problematic even in theory, with so many possible defects that can 
cause instability. An alternative is to accept that CIN will arise in tumours, and to look instead for 
therapies that can target such cells. From this perspective, the CIN phenotype is a therapeutic 
advantage, because CIN represents a significant difference from normal proliferating cells that may 
allow targeting of therapy to avoid damaging the patient. The question then is: can we find targets 
that can be disrupted to specifically induce death in CIN cells without affecting normal dividing 
cells? 
2. CIN models and their limitations 
An obvious approach to this problem is to get cultures of CIN cells, and screen them with 
chemical libraries to find anything that kills CIN, but not normal cells. To some extent this has been 
attempted [8], but there are several challenges with this approach. CIN lines are inherently 
varied—potentially every cell has a different genome, and each cell varies as it is cultured. This 
means that it is problematic to do reproducible experiments. However, the objective is to find 
generalizable therapies that affect any CIN cells, so in theory the approach can still work if enough 
chemicals are tested enough times. Using karyotypic heterogeneity as a proxy for CIN, the well 
characterized panel of 60 human cancer cell lines from the NCI has been used to identify drugs that 
preferentially affect karyotypically diverse cell lines [9,10]. Perhaps unsurprisingly, none of the 
current cancer therapeutics tested were particularly effective against the unstable cell lines. Some 
novel drug classes were found that could inhibit the growth of unstable lines with some specificity, 
however, as the authors comment, these correlations are a “blunt tool for drug discovery requiring 
secondary experimental confirmation” [10]. In addition, the cell lines used have inevitably arisen 
with constraints very different to those faced by tumours in vivo, and the most effective chemicals 
identified gave no clear idea of how they might be working. For these reasons it is valuable to have 
animal CIN tumour models in which specific and reproducible mechanisms for killing CIN cells can 
be identified and characterized. This review will focus on the development of CIN models in 
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3. Advantages of using Drosophila 
As an animal model for studying CIN, Drosophila has some significant advantages. It is now 
straightforward to manipulate the expression of any gene in Drosophila, at any stage of development 
in any tissue of interest. In the context of CIN, this means that animals can be grown that are 
genetically normal, with CIN induced by gene mis-expression in the proliferating tissue of choice 
when required. For example, the larval wing disc can be used to provide a testbed of cells that start 
out identical each time the experiment is done, while allowing the generation of a diverse set of CIN 
cells to study [11,12,13]. This avoids the issues of reproducibility faced when using CIN cell lines, as 
well as providing an in vivo epithelium that better reflects the environment of CIN tumours when 
they arise. This could theoretically be done in mice [14,15], but large scale screening in mice is 
impracticably time consuming and expensive. To identify and characterize novel mechanisms by 
which CIN cells can be specifically killed, it is useful to have an inducible in vivo system that allows 
genome-wide screening. Using Drosophila provides such a system as well as giving access to 
unparalleled resources for genetic analysis of any candidates identified [16]. This includes easy 
screening for genetic interactions, pathway dissection by epistasis and modelling of most of the 
hallmarks of cancer [17-21]. 
4. Drosophila CIN models 
As mentioned above, there are numerous mitotic processes that are known to give CIN when 
disrupted in cell culture or mouse models, and several of these have been exploited in Drosophila to 
create inducible CIN models. They can be broadly classified as disruption of the mitotic spindle, 
checkpoints, cytokinesis or DNA repair. 
4.1. Mitotic spindle disruption 
Defects in spindle structure or kinetochore dynamics represent straightforward mechanisms for 
generating CIN. For example, if the spindle is incorrectly formed with too many poles, then 
chromosome segregation is affected (Figure 1A). Centrosome number is frequently aberrant in 
cancers, so this form of CIN has been modelled by altering the levels of centrosome regulatory genes 
such as polo or sak, and showing that neural cells with aberrant numbers of centrosomes go on to 
form malignant and metastatic tumours in Drosophila [22,23]. It is interesting that although very 
little CIN was initially detected in the mutant brains, when they had been transplanted and grown in a 
host they became strikingly aneuploid. Exactly when and how the CIN arises in these models is not 
well characterized, but they appear to recapitulate human tumorigenesis in which CIN is generally 
not an early trigger, but arises in an already hyper-proliferative tissue. Another striking observation 
from cells with elevated centrosome numbers was that spindles are surprisingly effective at 
generating a bipolar array even with many extra centrosomes present, as long as the spindle 
checkpoint is working to allow enough time to cluster the centrosomes [23,24]. This checkpoint 
control is not completely effective in neuroblasts, though, which can lose the correct spindle 
alignment and cell polarity, leading to a failure to differentiate and consequent overproliferation. 
Interestingly, CIN tumours can also be made without altering the centrosomes simply by disrupting 
neuroblast polarity. In this case, again there is a failure to differentiate, and an expansion of 
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Figure 1. Drosophila CIN models: (A) An induced defect in centrosome number 
(wavy arrow) leads to a tripolar spindle. This is resolved into a bipolar array before 
anaphase, but one chromosome fails to segregate (arrow). (B) An induced defect in 
DNA damage repair or replication leads to still catenated chromatids (enlarged). At 
anaphase this leads to a chromosome bridge (arrow) that will break, leading to loss 
or gain of chromosome segments. (C) An induced spindle checkpoint defect means 
that a kinetochore attached to both poles (wavy arrow) may not be resolved before 
anaphase, leading to failure to segregate a lagging chromosome (arrow) that is 
attached to both poles. （D） An induced cytokinesis defect (wavy arrow) leads to no 
separation of daughter cells, and results in a binucleate cell with a tetraploid 
genome and an extra centrosome. 
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proliferative neuroblasts that can be transplanted to form malignant and metastatic tumours [25]. The 
initial neuroblasts are karyotypically normal, but become aneuploid and acquire centrosome defects 
as the tumour develops. From these studies and others [26] it seems that most tissues in Drosophila 
resist tumorigenesis from centrosome alterations by dying, but neuroblasts are an exception. In these 
cells, anything that expands the ‘stem-like’ population of transit amplifying lineage neuroblasts will 
tend to not only cause overgrowth, but also the acquisition of additional defects that cause CIN and 
allow metastatic tumour growth. It will be interesting to find out what changes arise so rapidly and 
frequently to transform overgrowing neuroblasts; recent work in this direction has implicated DNA 
damage [27]. 
4.2. Elevated DNA damage 
Mutations that either increase the rate of DNA damage or that reduce the cell’s ability to repair 
DNA damage are another type of CIN model available in Drosophila (Figure 1B). For example, high 
levels of instability can be induced by blocking tefu, the Drosophila homolog of ATM, which is 
needed for DNA damage repair and telomere maintenance [28]. Interestingly, ATM also acts as a 
redox sensor protein, so it is activated either by DNA damage itself or by oxidative stress that 
threatens the DNA [29]. Balancing the levels of cellular pro- and anti-oxidants is clearly important 
for cells, as too much of either is able to generate CIN [30]. Furthermore, the aneuploidy generated 
by CIN is known to cause oxidative stress [31], which can damage DNA to cause further aneuploidy, 
so there is potential for feedback reinforcement of initially minor oxidative insults. Sophisticated 
tools are now available in Drosophila to monitor the levels and locations of redox stress in live 
tissues [32]. DNA damage itself is harder to monitor live, but some markers are available [33,34]. It 
would be particularly useful to be able to monitor the persistence of DNA damage into mitosis, as 
there are many unresolved questions about chromosome bridges and the resolution of double strand 
breaks in mitosis. For example, replication stress can induce CIN [35], but it is not clear whether this 
mechanism is often found in CIN tumours [36]. Ultrafine anaphase bridges, which result from late 
decatenation of chromatids [37], represent another potential source of CIN that has not yet been 
explored in Drosophila. These bridges indicate an unexpected level of DNA processing during 
mitosis even after the DNA damage and spindle checkpoints have been passed. This may explain 
why mitotic stability is so dependent on DNA damage repair being completed in time. The need for 
efficient DNA repair has been highlighted by our work showing that CIN cells are particularly 
dependent on JNK signalling in G2 to prevent DNA damage accumulation and apoptosis [38]. Even 
just altering G2 duration strongly affects the survival of CIN cells; we suggest this is because CIN 
cells are particularly sensitive to entering mitosis with unrepaired DNA damage. If DNA damage or 
aneuploidy levels get too high, the JNK pathway is also used to drive apoptosis [13,26,39]. How the 
JNK pathway integrates multiple stress signals to decide between repair versus death is an area of 
active research [40,41,42]. 
4.3. Spindle assembly checkpoint mutations 
The best characterized cause of CIN is a failure in the spindle assembly checkpoint that allows 
segregation of chromosomes that are not correctly bioriented on the spindle (Figure 1C). There is 
abundant evidence that a defect in the spindle checkpoint in cell culture [43], animal models [44] or 
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humans [45], leads to CIN. Analysis of mutations found in tumours suggests that complete loss of 
spindle checkpoint proteins is rare [46], presumably because that would generate an intolerably high 
level of instability. However there are numerous examples of tumours in which the checkpoint is 
aberrant, either in protein levels or localization [44,47,48]. 
Using a defective spindle checkpoint as a CIN model has some advantages: the previously 
mentioned centrosomal and DNA damage models will tend to trigger checkpoints that promote cell 
cycle arrest and apoptosis rather than the desired unstable proliferation. In vertebrate systems, the 
level of spindle checkpoint disruption must be carefully controlled to avoid lethal levels of 
aneuploidy, but in Drosophila, the process of capturing the four chromosomes is sufficiently robust 
that even complete loss of the checkpoint can give viable animals [49]. This CIN model provides a 
perfect sensitized background for genetic screening in which even minor disruptions to genes needed 
for CIN cell survival can push these checkpoint compromised animals over the threshold of viability [11]. 
This screen tested the set of kinases and phosphatases and identified the JNK pathway and 
centrosomal signaling as key areas of CIN cell sensitivity. Although this type of viability screening 
has the benefit of being high-throughput, it has the drawback of a relatively non-specific phenotype: 
the death could be due to a range of developmental defects that would not be relevant to CIN 
tumours. However, further analysis allows confirmation that depleting the candidates by RNAi in 
proliferating CIN cells, such as the wing imaginal disc, can cause cell death [11]. This screen 
discarded mutations that were lethal in wild type as well as CIN animals, potentially missing some 
effective ways to kill CIN cells, however this approach should tend to identify more clinically useful 
approaches with fewer side effects on normal cells. Subsequent testing of good candidates in 
Drosophila tumour models [18] may allow confirmation that the genes in question are needed for the 
growth of bona fide CIN tumours. Our viability screen induced CIN by using RNAi to deplete the 
spindle checkpoint protein Mad2, but numerous alternative CIN models are available to confirm the 
generalizable effectiveness of candidates, including models depleting the checkpoint protein BubR1, 
or the cohesin Rad21 [38,50].  
Another use of spindle checkpoint CIN models in Drosophila has been to explore the fate of 
CIN cells if apoptosis is prevented [12,13]. Although the spindle checkpoint is not strictly needed for 
Drosophila survival, checkpoint mutants lose many cells to apoptosis as they grow, so preventing 
apoptosis allows analysis of the behaviour of the most aneuploid and aberrant cells, which might also 
be found in apoptosis-resistant cancers. These were found to activate the JNK pathway and drop out 
of the epithelium, a metastatic behaviour seen in other similarly “undead” cells [39,51]. 
4.4. Cytokinesis defects 
It has been noticed in human tumours that although they frequently show CIN and grossly 
aberrant karyotypes, in many cases the chromosome number seems to vary around a tetraploid rather 
than a diploid complement [52,53]. In some cases tetraploidy strongly predicts human tumour 
progression [54], and elegant studies in mice have shown that simply blocking one round of 
cytokinesis to give tetraploid cells can trigger tumorigenesis [55]. Drosophila is an excellent model 
system for studying cytokinesis—many of the genes and interactions that drive the process were 
discovered in flies [56-59]. Although there are numerous Drosophila RNAi lines that allow induction 
of cytokinesis failure and the generation of tetraploid cells, the relationship of tetraploidy to CIN 
development and tumorigenesis has not been intensively studied in flies [60]. Recent work showing 
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the involvement of the Hippo pathway in tetraploid cell survival [61] may prompt further 
investigation in this area. 
All these methods for generating CIN involve genetic disruption, but it is also possible to induce 
CIN chemically, for example by inhibiting kinesins with monastrol to cause monopolar spindle 
formation [62]. This approach has been used in vertebrate cell culture for some time, and has 
recently been developed in Drosophila by replacing the fly kinesin with the human version, which is 
sensitive to inhibition by small molecules [63]. Chemical induction of CIN has the advantage that it 
is convenient for developing high-throughput screening in culture, and by using Drosophila cells, it 
is convenient to then rapidly screen candidate hits in flies for in vivo phenotypes. 
5. Conclusion 
At the beginning of this review we posed a question of particular clinical interest: can we find 
targets that can be disrupted to specifically induce death in CIN cells without affecting normal 
dividing cells? Use of induced CIN models in Drosophila has allowed some significant progress to 
be made in this direction. It has been known for over a century that centrosomes are often aberrant in 
cancers [64], but studies in Drosophila have made it clear that just having the wrong number of 
centrosomes is not in itself enough to result in tumorigenesis [18], because either the spindle 
checkpoint can delay anaphase until a bipolar spindle has formed, or because the grossly aneuploid 
progeny will die by apoptosis. The striking exception to this generalization is also significant—in 
brains, neither the spindle checkpoint nor apoptosis are able to prevent tumorigenesis from 
neuroblasts that have lost their polarity cues. In these cells, too many or too few centrosomes or 
disruption of cortical polarity markers can all trigger failure to differentiate and hyperplasia that 
often progresses to metastatic tumours. It is not yet clear why neuroblasts are insensitive to genomic 
disruption that triggers apoptosis in other cells, but since human CIN tumours share this cell death 
resistance, either neuroblasts or disc cells with blocked apoptosis are appealing CIN models for 
looking at aneuploid cell behaviour [65]. 
The significance of centrosomes has been emphasized: in CIN cells even slight perturbation of 
the centrosomes tends to give cell death [11]. This is consistent with reports showing that the spindle 
checkpoint is needed to survive extra centrosomes [66]. The JNK pathway is also clearly implicated 
in CIN cell survival and proliferation. JNK is typically activated in response to cell stress, but it is 
important to recognize that it gives two possible outcomes: if the stress is low level it promotes repair, 
whereas if the stress is acute, JNK promotes apoptosis [40]. Consequently, blocking JNK signalling 
in CIN cells can either cause their death through failed DNA repair [11,38] or prevent their death in 
response to gross aneuploidy [13,26]. Although targeting either centrosomes or JNK signalling may 
allow effective manipulation of CIN cell fates, neither is ideal as a clinical target, due to their critical 
functions in normal cells. An alternative that may offer better clinical promise is to genetically or 
chemically target the metabolism of CIN cells. We have found that CIN cells are highly sensitive to 
RNAi knockdowns that give a range of mild metabolic perturbations that do not affect normal cells [50]. 
Some of these (e.g. Pas Kinase) may be amenable to chemical inhibition. It is known that aneuploid 
cells experience redox stress [67], so one possible hypothesis is that CIN cells, with their ongoing 
and varied aneuploidy, are close to the limits of their ability to buffer redox stress, and hence are 
vulnerable to metabolic intervention. Because tumours frequently display an aberrant metabolism as 
well as chromosomal instability, there are reasons to hope that metabolic therapy may be effective at 
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generating tumour-specific apoptosis with minimal side effects [68]. 
There are a number of remaining challenges in understanding the causes and cellular responses 
to CIN. For example we still have no clear explanation for why the many varied genotypes generated 
in CIN populations so frequently seem to give the same stereotypical cell phenotype that includes 
overactive mitochondria, reactive oxygen species production, activation of the JNK pathway etc. It 
may be simply that any gene dosage variation gives protein folding stress [69], but we suspect that 
there may be other mechanisms that contribute to the response to aneuploidy. For example, many 
organisms can partially buffer gene dosage changes by down- or up-regulating the expression of 
genes in trisomic or monosomic DNA segments [70,71]. Several dosage compensation mechanisms 
exist for ensuring equal gene expression from sex chromosomes in males and females [72], and there 
are suggestions that extra somatic chromosomes can be shut down by nuclear compartmentalization [73], 
so it will be interesting to see whether CIN cells use similar processes to allow tolerance of gross 
aneuploidy. Because CIN develops fairly rapidly in Drosophila tumour models [25], they may be 
ideal for characterizing the acquisition of the changes that result in cells not only tolerating aberrant 
karyotypes, but also going on to proliferate and metastasize. 
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